Prev：Is endocan a biochemical marker for asymptomatic target organ damage in hypertensivepatients?(KTE62398-0.33)
Next：Multiple comparisons of three different sources of biomaterials in the application of tumor tissue engineering in vitro and in vivo(KTE62728-4.11)
